345 related articles for article (PubMed ID: 9375705)
21. Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.
Mizuno H; Sugiyama Y; Ohro Y; Imamine H; Kobayashi M; Sasaki S; Uchida S; Togari H
Endocrine; 2004 Jun; 24(1):55-9. PubMed ID: 15249704
[TBL] [Abstract][Full Text] [Related]
22. Copeptin role in polyuria-polydipsia syndrome differential diagnosis and reference range in paediatric age.
Tuli G; Tessaris D; Einaudi S; Matarazzo P; De Sanctis L
Clin Endocrinol (Oxf); 2018 Jun; 88(6):873-879. PubMed ID: 29464737
[TBL] [Abstract][Full Text] [Related]
23. Quality of life in the patients with central diabetes insipidus assessed by Nagasaki Diabetes Insipidus Questionnaire.
Nozaki A; Ando T; Akazawa S; Satoh T; Sagara I; Horie I; Imaizumi M; Usa T; Yanagisawa RT; Kawakami A
Endocrine; 2016 Jan; 51(1):140-7. PubMed ID: 26024973
[TBL] [Abstract][Full Text] [Related]
24. Juvenile-onset gout and adipsic diabetes insipidus: A case report and literature review.
Zhang Y; Wang D; Feng Y; Zhang W; Zeng X
J Int Med Res; 2018 Nov; 46(11):4829-4836. PubMed ID: 30270804
[TBL] [Abstract][Full Text] [Related]
25. Severe hypernatremia after cesarean delivery secondary to transient diabetes insipidus of pregnancy.
Sherer DM; Cutler J; Santoso P; Angus S; Abulafia O
Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1166-8. PubMed ID: 14607044
[TBL] [Abstract][Full Text] [Related]
26. Effect of DDAVP on nocturnal enuresis in a patient with nephrogenic diabetes insipidus.
Jonat S; Santer R; Schneppenheim R; Obser T; Eggert P
Arch Dis Child; 1999 Jul; 81(1):57-9. PubMed ID: 10373137
[TBL] [Abstract][Full Text] [Related]
27. The abnormal quinine drinking aversion in the Brattleboro rat with diabetes insipidus is reversed by the vasopressin agonist DDAVP: a possible role for vasopressin in the motivation to drink.
Laycock JF; Chatterji U; Seckl JR; Gartside IB
Physiol Behav; 1994 Mar; 55(3):407-12. PubMed ID: 8190753
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Pitfalls of a Newborn with Congenital Nephrogenic Diabetes Insipidus.
Güran Ö; Güven S; Kırmızıbekmez H; Akgün Doğan Ö; Karadeniz Bilgin L
J Clin Res Pediatr Endocrinol; 2023 Feb; ():. PubMed ID: 36815512
[TBL] [Abstract][Full Text] [Related]
29. The clinical pattern of diabetes Insipidus in a large university hospital in the Middle East.
Babiker AM; Al Jurayyan NA; Al Jurayyan RN; Al Gadi I; Drop SL
J Trop Pediatr; 2015 Apr; 61(2):100-5. PubMed ID: 25587001
[TBL] [Abstract][Full Text] [Related]
30. Diabetes insipidus in pregnancy: how to advice the patient?
Refardt J; Christ-Crain M
Minerva Endocrinol; 2018 Dec; 43(4):458-464. PubMed ID: 29463074
[TBL] [Abstract][Full Text] [Related]
31. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.
Bardoux P; Bichet DG; Martin H; Gallois Y; Marre M; Arthus MF; Lonergan M; Ruel N; Bouby N; Bankir L
Nephrol Dial Transplant; 2003 Mar; 18(3):497-506. PubMed ID: 12584270
[TBL] [Abstract][Full Text] [Related]
32. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
Kobrinsky NL; Doyle JJ; Israels ED; Winter JS; Cheang MS; Walker RD; Bishop AJ
Lancet; 1985 Jun; 1(8441):1293-4. PubMed ID: 2860491
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of V1a receptor increases renal uric acid clearance via urate transporters: insight into pathogenesis of hypouricemia in SIADH.
Taniguchi K; Tamura Y; Kumagai T; Shibata S; Uchida S
Clin Exp Nephrol; 2016 Dec; 20(6):845-852. PubMed ID: 26935049
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic value of the determination of blood urea in dehydrated patients with and without central diabetes insipidus].
Comtois R; Bertrand S; Beauregard H; Vinay P
Union Med Can; 1990; 119(6):317-21. PubMed ID: 2075636
[TBL] [Abstract][Full Text] [Related]
35. Nephrogenic diabetes insipidus: a comprehensive overview.
Vaz de Castro PAS; Bitencourt L; de Oliveira Campos JL; Fischer BL; Soares de Brito SBC; Soares BS; Drummond JB; Simões E Silva AC
J Pediatr Endocrinol Metab; 2022 Apr; 35(4):421-434. PubMed ID: 35146976
[TBL] [Abstract][Full Text] [Related]
36. [Hyperuricacidemic nephrogenic diabetes insipidus].
Lengyel I
Orv Hetil; 1991 Nov; 132(46):2551-2. PubMed ID: 1811206
[TBL] [Abstract][Full Text] [Related]
37. Familial forms of diabetes insipidus: clinical and molecular characteristics.
Babey M; Kopp P; Robertson GL
Nat Rev Endocrinol; 2011 Jul; 7(12):701-14. PubMed ID: 21727914
[TBL] [Abstract][Full Text] [Related]
38. A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.
Fenske W; Refardt J; Chifu I; Schnyder I; Winzeler B; Drummond J; Ribeiro-Oliveira A; Drescher T; Bilz S; Vogt DR; Malzahn U; Kroiss M; Christ E; Henzen C; Fischli S; Tönjes A; Mueller B; Schopohl J; Flitsch J; Brabant G; Fassnacht M; Christ-Crain M
N Engl J Med; 2018 Aug; 379(5):428-439. PubMed ID: 30067922
[TBL] [Abstract][Full Text] [Related]
39. Central Diabetes Insipidus in Infancy With or Without Hypothalamic Adipsic Hypernatremia Syndrome: Early Identification and Outcome.
Djermane A; Elmaleh M; Simon D; Poidvin A; Carel JC; Léger J
J Clin Endocrinol Metab; 2016 Feb; 101(2):635-43. PubMed ID: 26588450
[TBL] [Abstract][Full Text] [Related]
40. [Nephrogenic diabetes insipidus].
Radó J
Orv Hetil; 1998 Mar; 139(10):559-63. PubMed ID: 9538640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]